Logo image of MEGL

MAGIC EMPIRE GLOBAL LTD-A (MEGL) Stock Fundamental Analysis

NASDAQ:MEGL - Nasdaq - VGG5865E1218 - Common Stock - Currency: USD

1.6  +0.04 (+2.58%)

Premarket: 1.53 -0.07 (-4.38%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to MEGL. MEGL was compared to 233 industry peers in the Capital Markets industry. No worries on liquidiy or solvency for MEGL as it has an excellent financial health rating, but there are worries on the profitability. MEGL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year MEGL has reported negative net income.
In the past year MEGL has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: MEGL reported negative net income in multiple years.
In multiple years MEGL reported negative operating cash flow during the last 5 years.
MEGL Yearly Net Income VS EBIT VS OCF VS FCFMEGL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

1.2 Ratios

MEGL has a Return On Assets of -3.48%. This is amonst the worse of the industry: MEGL underperforms 81.55% of its industry peers.
With a Return On Equity value of -3.64%, MEGL is not doing good in the industry: 76.82% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -3.48%
ROE -3.64%
ROIC N/A
ROA(3y)-2.16%
ROA(5y)5.08%
ROE(3y)-2.27%
ROE(5y)25.92%
ROIC(3y)N/A
ROIC(5y)N/A
MEGL Yearly ROA, ROE, ROICMEGL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 50 100 150 200 250

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for MEGL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MEGL Yearly Profit, Operating, Gross MarginsMEGL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

9

2. Health

2.1 Basic Checks

Compared to 1 year ago, MEGL has about the same amount of shares outstanding.
MEGL has more shares outstanding than it did 5 years ago.
MEGL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MEGL Yearly Shares OutstandingMEGL Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
MEGL Yearly Total Debt VS Total AssetsMEGL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

An Altman-Z score of 5.51 indicates that MEGL is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 5.51, MEGL belongs to the best of the industry, outperforming 85.84% of the companies in the same industry.
There is no outstanding debt for MEGL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.51
ROIC/WACCN/A
WACCN/A
MEGL Yearly LT Debt VS Equity VS FCFMEGL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 37.01 indicates that MEGL has no problem at all paying its short term obligations.
With an excellent Current ratio value of 37.01, MEGL belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
MEGL has a Quick Ratio of 37.01. This indicates that MEGL is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 37.01, MEGL belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 37.01
Quick Ratio 37.01
MEGL Yearly Current Assets VS Current LiabilitesMEGL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for MEGL have decreased strongly by -840.00% in the last year.
The Revenue has decreased by -7.33% in the past year.
MEGL shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -14.20% yearly.
EPS 1Y (TTM)-840%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-341.67%
Revenue 1Y (TTM)-7.33%
Revenue growth 3Y-8.32%
Revenue growth 5Y-14.2%
Sales Q2Q%-34.38%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MEGL Yearly Revenue VS EstimatesMEGL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MEGL. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MEGL Price Earnings VS Forward Price EarningsMEGL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MEGL Per share dataMEGL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MEGL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAGIC EMPIRE GLOBAL LTD-A

NASDAQ:MEGL (7/1/2025, 8:46:40 PM)

Premarket: 1.53 -0.07 (-4.38%)

1.6

+0.04 (+2.58%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)12-13 2022-12-13/bmo
Inst Owners0.98%
Inst Owner ChangeN/A
Ins Owners40.31%
Ins Owner ChangeN/A
Market Cap6.50M
AnalystsN/A
Price TargetN/A
Short Float %14.76%
Short Ratio0.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.99
P/FCF N/A
P/OCF N/A
P/B 0.39
P/tB 0.39
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.15
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS0.4
BVpS4.06
TBVpS4.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.48%
ROE -3.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-2.16%
ROA(5y)5.08%
ROE(3y)-2.27%
ROE(5y)25.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 37.01
Quick Ratio 37.01
Altman-Z 5.51
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-840%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-341.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.33%
Revenue growth 3Y-8.32%
Revenue growth 5Y-14.2%
Sales Q2Q%-34.38%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-264.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-156.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5266.67%
OCF growth 3YN/A
OCF growth 5YN/A